These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28099538)

  • 1. Psoriasis treatment considerations in military patients: unique patients, unique drugs.
    Evans T; Davidson N; Logemann N
    Cutis; 2016 Dec; 98(6):370-373. PubMed ID: 28099538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of methotrexate in patients with psoriasis.
    Kuhn A; Ruland V; Patsinakidis N; Luger TA
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S138-44. PubMed ID: 21044448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.
    Famenini S; Wu JJ
    Cutis; 2013 Sep; 92(3):140-7. PubMed ID: 24153143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs in the treatment of psoriasis.
    DiSepio D; Chandraratna RA
    Expert Opin Investig Drugs; 2000 Jan; 9(1):79-93. PubMed ID: 11060662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of new biological therapy in psoriasis treatment].
    Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A
    Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment.
    Laino L; DiCarlo A
    Arch Dermatol; 2011 Jun; 147(6):760. PubMed ID: 21690553
    [No Abstract]   [Full Text] [Related]  

  • 12. An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
    Campa M; Ryan C; Menter A
    Expert Opin Investig Drugs; 2015; 24(10):1343-54. PubMed ID: 26289788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
    Van Lümig PP; Lecluse LL; Driessen RJ; Spuls PI; Boezeman JB; van de Kerkhof PC; De Jong EM
    Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New systemic treatments for psoriasis: etanercept, infliximab, adalimumab, efalizumab and alefacept].
    Bos WE; Thio HB; Neumann HA; van der Fits L; Prens EP
    Ned Tijdschr Geneeskd; 2006 May; 150(19):1065-70. PubMed ID: 16733982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of generalized pustular psoriasis treated with topical tacrolimus.
    Nagao K; Ishiko A; Yokoyama T; Tanikawa A; Amagai M
    Arch Dermatol; 2003 Sep; 139(9):1219. PubMed ID: 12975175
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dear-Doctor-Letter Fumaderm® - What are the facts?
    Mrowietz U; Reich K
    J Dtsch Dermatol Ges; 2013 Oct; 11(10):1016-7. PubMed ID: 23957558
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.
    Brimhall AK; King LN; Licciardone JC; Jacobe H; Menter A
    Br J Dermatol; 2008 Aug; 159(2):274-85. PubMed ID: 18547300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.